https://www.glp1digest.com/archivedailyhttps://www.glp1digest.com/aboutweeklyhttps://www.glp1digest.com/podcastweeklyhttps://www.glp1digest.com/p/india-is-not-the-opportunity-you2026-03-26monthlyhttps://www.glp1digest.com/p/should-glp-1s-be-sold-over-the-counter2026-03-08monthlyhttps://www.glp1digest.com/p/what-investors-get-wrong-about-hims2026-03-01monthlyhttps://www.glp1digest.com/p/the-glp-1-business-model-problem2026-02-15monthlyhttps://www.glp1digest.com/p/glp-1s-go-to-the-super-bowl2026-02-08monthlyhttps://www.glp1digest.com/p/consumer-health-apps-are-dead2026-01-11monthlyhttps://www.glp1digest.com/p/the-5-most-important-ideas-for-20262025-12-30monthlyhttps://www.glp1digest.com/p/is-your-telehealth-platform-scaring2025-12-16monthlyhttps://www.glp1digest.com/p/when-science-fails-and-startups-fly2025-11-25monthlyhttps://www.glp1digest.com/p/who-won-trumps-glp-1-drug-deal2025-11-11monthlyhttps://www.glp1digest.com/p/why-cant-anyone-stop-compounded-glp2025-11-03monthlyhttps://www.glp1digest.com/p/what-comes-after-the-glp-1-hype2025-09-28monthlyhttps://www.glp1digest.com/p/when-glp-1s-become-brain-drugs2025-09-14monthlyhttps://www.glp1digest.com/p/why-novo-nordisk-and-eli-lilly-wont2025-09-01monthlyhttps://www.glp1digest.com/p/the-100-billion-overreaction2025-08-24monthlyhttps://www.glp1digest.com/p/when-britains-glp-1-prices-are-set2025-08-17monthlyhttps://www.glp1digest.com/p/why-novo-nordisk-is-out-of-options2025-08-05monthlyhttps://www.glp1digest.com/p/the-glp-1-threat-to-alcohol2025-07-13monthlyhttps://www.glp1digest.com/p/glp-1s-are-quietly-killing-your-cravings2025-07-06monthlyhttps://www.glp1digest.com/p/hims-has-no-way-out-of-their-7252025-06-29monthlyhttps://www.glp1digest.com/p/how-glp-1s-are-breaking-life-insurance2025-06-22monthlyhttps://www.glp1digest.com/p/why-novo-nordisk-wont-beat-eli-lilly2025-06-15monthlyhttps://www.glp1digest.com/p/how-a-tiny-british-startup-became2025-06-08monthlyhttps://www.glp1digest.com/p/what-do-glp-1-patients-actually-want2025-06-01monthlyhttps://www.glp1digest.com/p/are-you-ready-for-the-on-off-reality2025-05-25monthlyhttps://www.glp1digest.com/p/stop-calling-glp-1s-a-trend2025-05-19monthlyhttps://www.glp1digest.com/p/hims-is-quietly-building-a-consumer2025-05-11monthlyhttps://www.glp1digest.com/p/who-wins-and-loses-in-pharmas-latest2025-05-04monthlyhttps://www.glp1digest.com/p/is-your-glp-1-strategy-future-proof2025-04-27monthlyhttps://www.glp1digest.com/p/why-your-ozempic-wont-cost-moreeven2025-04-24monthlyhttps://www.glp1digest.com/p/the-real-reason-weight-loss-drugs2025-04-04monthlyhttps://www.glp1digest.com/p/the-suffering-economy-is-over2025-04-03monthlyhttps://www.glp1digest.com/p/coming-soon2025-06-19monthly